Don't you wish your PCR device could be this handy? Get on board with Doctor Vida!

Product : Doctor Vida Pocket

STAB VIDA is proud and honored to be in the European Pavilion with the European Innovation Council and SMEs Executive Agency (EISMEA) delegation at Arab Health in Dubai. STAB VIDA is exhibiting Doctor Vida Pocket PCR joining the Overseas Trade Fairs Programme at Arab Health Za'abeel Hall 6 – Booths  Z6.C24


You can come anytime! No pre-booking!

Our CEO and founder Doctor Orfeu Flores and Doctor Vida Sales and R&D Team will be happy to introduce you to our vision and the diagnostic solution we develop. We will be excited to meet with clients, agents and investors.


Doctor Vida is the smallest portable PCR device for diagnostics of COVID-19, lactose intolerance and other diseases, already in the market, CE-IVD, fullY developed and ISO 13485 manufactured by STAB VIDA. It is unique and all-in-one testing cycle: kit for sample collection, reagents for isothermal DNA/RNA amplification and detection, pocket-sized device and an APP that delivers the final patient's diagnostics report, in less than 1 hour.

Doctor Vida is a highly innovative portable, handheld device for isothermal nucleic acid amplification of genetic biomarkers. Operated from any smartphone in a clinical or research setting, but also at home, at the office, etc.

Doctor Vida is under clinical trials for point of care of EGFR testing of NSCLC, as a companion diagnostic, Legionella, HIV, HPV, Zika (viral load), gluten intolerance and veterinarian applications.

For example the occurrence of clinical important mutations in the EGFR gene in Lung cancer patients varies in terms of race; it is around 10% in Caucasians and can reach 30% in Asians. Our Doctor Vida Pocket PCR targets in less than 1 h, full point of care, to faster identify the treatment of lung adenocarcinomas. Doctor Vida is now in all continents and recently started business with a distributor for Asia, selling already to Indonesia and for other countries within the region.

Potential impact

STAB VIDA a Portuguese biotech with its patented smallest genetic laboratory of the world, a pocket PCR device and a phone´s app, wants to find worldwide distributors and licensees. We want to contact and negotiate with a pharmacy's chain, clinics and chain of veterinary testing centers with many spots all over the Arab countries in MENA, namely UAE, SA, Kuwait, Egypt, Jordan, Qatar, etc, in order to penetrate our point of care technology of PCR testing (Covid-19 and other infectious diseases, EGFR, lactose and other food intolerances and also veterinarian applications) in a decentralized lab setting, communicating with the client's smartphones automatically.

The sales price of each Pocket PCR will be 330 $ and the sales price of each PCR test will be 15-80 $ depending on the disease.

The point-of-care diagnostics market is witnessing significant growth, owing to the increasing usage of POC tests that can rapidly diagnose diseases.

As an example, the lung cancer segment is expected to hold a significant share in the market. Companion diagnostic tests (CDXs) are considered mandatory in decision-making for treatment with targeted therapies in lung cancer.

Moreover, the food allergen testing market in the MENA is expected to grow from US$ 55.45 million in 2018 to US$ 98.28 million by 2027; it is estimated to grow at a CAGR of 6.6% during 2019–2027. 

As for Legionella, travel-associated Legionnaires’ disease (TALD) cases with a history of travel to Dubai, United Arab Emirates were reported to the European Centre for Disease Prevention and Control from 14 European Union countries. Early testing can improve in managing future outbreaks of TALD.

We are seeking for more licensees of the technology, in exchange for an upfront fee and generated royalties from the sales. We are also seeking an IP agent in Asia that combines expertise with Asia regulatory filling and approval, and all necessary registrations to ensure freedom to operate.

We have published a paper in collaboration with a contact in King Saud Bin Abdulaziz's University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia: An isothermal lab-on-phone test for easy molecular diagnosis of SARS-CoV-2 near patients and in less than 1 hour - International Journal of Infectious Diseases (

The MENA region’s leading exhibitions for the healthcare and laboratory industries has revealed that investment in new healthcare technology has become the top priority. We want to better understand the MENA POC testing market landscape and identify top market segments that are likely to guarantee a strong return.

We want to exhibit our cutting-edge device Doctor Vida, a small and portable but at the same time sophisticated medical solution that fits the future of the healthcare sector: diagnostic gadgets at home, the clinical laboratory inside a pocket, people's own laboratory on a phone. Digital health technologies have been identified as promising solutions to address the challenges of health planning and management, and in MENA countries, the POC solutions have the potential to play an essential role.

We are looking for establishing new licensing deals and distributors partnerships, gain knowledge and strengthen business ties with the global medical device and equipment market, so ARAB HEALTH is the event leading platform that meets our needs. We want to meet partners that already operate in the market of disposables & consumables, healthcare IT systems / solutions, Imaging & Diagnostics, Laboratory, Medical Equipment & Devices.

We need to meet with some of the best professionals in the field and connect with the right large-scale industries well established in MENA.

We also want to meet with potential partners that represent chains of pharmacies, chains of clinics and chains of veterinary testing centers.

Doctor Vida Pocket video: